Study S001490

Efficacy of Tirzepatide for Weight Management in Patients With Suboptimal Weight Loss After Bariatric Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07829198
Acronym: TirBaS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 70
Start: 2027-01
Primary completion: 2028-12
Lead sponsor: Universidade do Porto
Conditions: Obesity
Interventions: DRUG:Tirzepatide; DRUG:Placebo
Results posted: FALSE
Secondary identifiers: CTIS:2026-527275-29-00

Registered primary outcomes

Percentage Change in Body Weight from Baseline to Week 52 [Baseline (Week 0) to Week 52]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.